(Q31933342)

5 July 2017

1 reference

title

Evaluation of patients with CNS involvement in SLE. (English)

1 reference

5 July 2017

Hanly JG

1

1 reference

5 July 2017

1 August 1998

1 reference

Bailliere's clinical rheumatology

5 July 2017

1 reference

5 July 2017

12

1 reference

5 July 2017

3

1 reference

5 July 2017

415-431

1 reference

MR imaging of systemic lupus erythematosus involving the brain.

5 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

The antiphospholipid-protein syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

1 reference

7 January 2021

Patterns of cognitive impairment in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

A Controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Cognitive disorders in systemic lupus erythematosus. Epidemiologic and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Psychiatric disorder and cognitive impairment in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

The neurological manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Antiserum to brain gangliosides produces recurrent epileptiform activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

The effect of antisynaptosomal plasma membrane antibodies on memory

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Cerebral blood flow variations in CNS lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

A Clinical Perspective on SPECT

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric symptoms: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Immunology of the antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

The lupus anticoagulant/antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Interferon-alpha in lupus psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Positron emission tomography in neuropsychiatric lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Brain scan diagnosis of central nervous system involvement in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

The pathogenesis of central nervous system manifestations of systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2898%2980028-9

7 January 2021

10.1016/S0950-3579(98)80028-9

Identifiers

DOI

1 reference

5 July 2017

1 reference

PubMed ID

9890105